GSK plc announced it purchased 325,000 ordinary shares at a price range of 2,157.00p to 2,196.00p on April 10, 2026. This transaction is part of an ongoing buyback program, bringing total shares purchased since February 17, 2026, to 18,221,521 shares, leaving 258,112,615 shares in treasury out of 4,058,078,154 total shares issued.